PHOTO
Titled “Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months,” the study, published on Sept. 15, was conducted on more than 45,000 participants in 152 sites in six countries.
The study concluded that “through 6 months of follow-up and despite a gradual decline in vaccine efficacy, BNT162b2 had a favorable safety profile and was highly efficacious in preventing COVID-19.”
“The vaccine still provides protection against severe disease even six months after the second dose,” said Al-Hakawi, who is also a hospital epidemiologist in Riyadh.
Saudi Arabia recorded 68 new cases of coronavirus disease (COVID-19) on Saturday, bringing the total number of confirmed cases to 546,479, the Ministry of Health said.
New recoveries reported amounted to 77, raising the total number to 535,450.
With the high recovery rate, the number of active cases has declined to 2,373, of which 361 are in critical care.
Five people have died in the past 24 hours, raising the total number of deaths to 8,656.
Copyright: Arab News © 2021 All rights reserved. Provided by SyndiGate Media Inc. (Syndigate.info).